Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by HighteawithIntrepidon May 29, 2017 5:46pm
151 Views
Post# 26297707

RE:RE:RE:RE:RE:biofinder thanks for

RE:RE:RE:RE:RE:biofinder thanks forI throw out the high and low and average the
others and say between 4-5 in a year, if we get a yes
and find some money to get there. The lack of freeboard 
on the daily burn has us taking on water far sooner than 
the believers think. PLI have a better handle on the science 
than the markets. The believers don't like canaries so awaiting 
the opening of a local brew pub. The more BIO rehashes the old science 
the more I think he is acknowledging our side of the coin.
Bullboard Posts